Almirall licenses its products based on value and project development needs. We offer attractive products, developed in compliance with deontological regulations and applying the criteria established in the International Conference on Harmonisation (ICH) guidelines.
Throughout the development phases of a new molecule, to guarantee the quality and safety of the work, Almirall also applies Good Laboratory Practices (GLP), Good Clinical Practices (GCP) and Good Manufacturing Practices (GMP), bearing in mind respect for the environment at all times.
We are actively looking for partners to license our products. According to our licensing strategy, we are also open to the possibility of licensing our products in earlier phases, after proof of concept (Phase IIa).